REGISTERED NUMBER: 12060630 (England and Wales)

Financial Statements

for the Year Ended 31 March 2026

for

TRUPCR Europe Limited

Page

Company Information

1

Balance Sheet

2

Notes to the Financial Statements

4

DIRECTORS:

H Singh

N K Dubey

D Dubey

REGISTERED OFFICE:

Unit 6, Williams House

Lloyd Street North

Manchester Science Park

Manchester

M15 6SE

REGISTERED NUMBER:

12060630 (England and Wales)

SENIOR STATUTORY AUDITOR:

Ian Sluckis BA FCA

AUDITORS:

Freedman Frankl & Taylor

Statutory Auditors

Chartered Accountants

Reedham House

31 King Street West

Manchester

M3 2PJ

FIXED ASSETS

Intangible assets

3

-

2,796

Tangible assets

4

68,590

73,785

Investments

5

829,500

-

898,090

76,581

CURRENT ASSETS

Stocks

6

47,039

54,473

Debtors

7

562,991

271,825

Cash at bank

393,565

559,747

1,003,595

886,045

CREDITORS

Amounts falling due within one year

8

(712,549

)

(184,234

)

NET CURRENT ASSETS

291,046

701,811

TOTAL ASSETS LESS CURRENT LIABILITIES

1,189,136

778,392

CREDITORS

Amounts falling due after more than one year

9

(262,500

)

(1,000

)

NET ASSETS

926,636

777,392

CAPITAL AND RESERVES

Called up share capital

11

1,000

1,000

Share premium

869,400

869,400

Retained earnings

56,236

(93,008

)

SHAREHOLDERS' FUNDS

926,636

777,392

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Statement of Comprehensive Income has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 30 June 2026 and were signed on its behalf by:

H Singh - Director

N K Dubey - Director

1.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Significant judgements and estimates

In applying the company's accounting policies, the directors are required to make judgements, estimates and assumptions in determining the carrying amounts of assets and liabilities. The directors' judgements, estimates and assumptions are based on the best and most reliable evidence available at the time when the decisions are made, and are based on historical experience and other factors that are considered to be applicable. Due to the inherent subjectivity involved in making such judgements, estimates and assumptions, the actual results and outcomes may differ.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revision to accounting estimates are recognised in the period in which the estimate is revised, if the revision affects only that period, or in the period of the revision and future periods, if the revision affects both current and future periods.

Key sources of estimation uncertainty

The key assumptions concerning the future, and other key sources of estimation uncertainty, that have a significant risk of causing a material adjustment to the carrying amounts of assets and liabilities within the next financial year are disclosed below.

Assessing indicators of impairment

In assessing whether there have been any indicators of impairment assets, the directors have considered both external and internal sources of information such as market conditions and experience of recoverability. There have been no indicators of impairments identified during the current financial year.

Tangible fixed assets

Tangible fixed assets, are depreciated over their useful lives taking into account residual values, where appropriate. The actual lives of the assets and residual values are assessed annually and may vary depending on a number of factors. In re-assessing asset lives, factors such as technological innovation, product life cycles and maintenance programmes are taken into account. Residual value assessments consider issues such as future market conditions, the remaining life of the asset and projected disposal values.

Turnover

Revenue is recognised to the extent that it is probable that the economic benefits will flow to the company and the revenue can be reliably measured. Revenue is measured as the fair value of the consideration received or receivable, excluding discounts, rebates and value added tax.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership have transferred to the buyer (usually on despatch of the goods); the amount of revenue can be measured reliably; it is probable that the associated economic benefits will flow to the entity; and the costs incurred or to be incurred in respect of the transactions can be measured reliably.

Interest Income

Interest income is recognised on an accrual basis, when the entity obtains the right to receive the income.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Development costs are being amortised evenly over their estimated useful life of three years.

Tangible fixed assets

Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Improvements to property

-

The period of the lease

Plant and machinery

-

Straight line over 15 years

Fixtures and fittings

-

Straight line over 10 years

Computer equipment

-

Straight line over 3 years

Tangible fixed assets are recorded at cost less any tax, discounts and rebates. Subsequently they are recorded at cost less accumulated depreciation and impairment.

Government grants

Grants of a revenue nature are credited to income in the period to which they relate.

Investments in associates

Investments in associate undertakings are recognised at cost.

Stocks

Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow moving items.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the balance sheet date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance sheet date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Research and development

Expenditure on research and development is written off in the year in which it is incurred.

Foreign currencies

Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the balance sheet date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

Hire purchase and leasing commitments

Rentals paid under operating leases are charged to profit or loss on a straight line basis over the period of the lease.

Pension costs and other post-retirement benefits

The company operates a defined contribution pension scheme. Contributions payable to the company's pension scheme are charged to profit or loss in the period to which they relate.

Going concern

The company's financial statements for the year ended 31 March 2026 have been prepared on a going concern basis as, after making appropriate enquiries, the directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future.

Contingent liabilities

Deferred consideration is recognised at the fair value of the amount expected to be paid. Where the settlement is deferred beyond normal credit terms, the liability is measured at the present value of the future payments, discounted at a market rate of interest for a similar debt instrument. The unwinding of the discount is recognised as a finance cost in the Profit and Loss account over the period of deferral.

2.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 8 (2025 - 6 ) .

3.	INTANGIBLE FIXED ASSETS

Development

costs

£

COST

At 1 April 2025

and 31 March 2026

8,389

AMORTISATION

At 1 April 2025

5,593

Amortisation for year

2,796

At 31 March 2026

8,389

NET BOOK VALUE

At 31 March 2026

-

At 31 March 2025

2,796

4.	TANGIBLE FIXED ASSETS

Improvements

Fixtures

to

Plant and

and

Computer

property

machinery

fittings

equipment

Totals

£

£

£

£

£

COST

At 1 April 2025

35,915

72,965

6,597

3,981

119,458

Additions

110

1,441

902

1,810

4,263

At 31 March 2026

36,025

74,406

7,499

5,791

123,721

DEPRECIATION

At 1 April 2025

28,437

12,944

1,886

2,406

45,673

Charge for year

2,530

4,897

683

1,348

9,458

At 31 March 2026

30,967

17,841

2,569

3,754

55,131

NET BOOK VALUE

At 31 March 2026

5,058

56,565

4,930

2,037

68,590

At 31 March 2025

7,478

60,021

4,711

1,575

73,785

5.	FIXED ASSET INVESTMENTS

Interest

in

associate

£

COST

Additions

829,500

At 31 March 2026

829,500

NET BOOK VALUE

At 31 March 2026

829,500

The company investments at the balance sheet date in the share capital of unlisted companies include the following:

Coris Holdings SRL

Registered office: Rue Guillaume Fouquet 11, 5032 Gembloux, Belgium

Nature of business: Activities of holding companies

%

Class of shares:

holding

Ordinary shares

30.00

6.

STOCKS

2026

2025

£

£

Good for resale

47,039

54,473

7.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2026

2025

£

£

Trade debtors

427,054

231,913

Other debtors

135,937

39,912

562,991

271,825

8.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

2026

2025

£

£

Trade creditors

11,330

8,401

Amounts owed to group undertakings

493,233

161,904

Taxation and social security

5,022

-

Other creditors

202,964

13,929

712,549

184,234

9.

CREDITORS: AMOUNTS FALLING DUE AFTER MORE THAN ONE YEAR

2026

2025

£

£

Amounts owed to group undertakings

262,500

-

Other creditors

-

1,000

262,500

1,000

10.	LEASING AGREEMENTS

Minimum lease payments under non-cancellable operating leases fall due as follows:

2026

2025

£

£

Within one year

39,248

16,849

Between one and five years

58,872

-

98,120

16,849

11.	CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:

Number:

Class:

Nominal

2026

2025

value:

£

£

1,000

Ordinary

£1

1,000

1,000

12.	DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Ian Sluckis BA FCA (Senior Statutory Auditor)

for and on behalf of Freedman Frankl & Taylor

13.	CONTINGENT LIABILITIES

Contingent consideration is payable in relation to the acquisition of the group undertaking. The amount recognised of £184,500 represents the directors' best estimate of the liability due under the terms of the purchase agreement, based on management’s performance expectations.

14.	RELATED PARTY DISCLOSURES

During the year company was charged consultancy fees amounting to £71,950 (2025: £86,250) by a company in which a director of TRUPCR Europe Limited is also a director. At the year end, the amount owed from the company was £6,420 (2025: £6,420).

15.	ULTIMATE CONTROLLING PARTY

The ultimate controlling party of TRUPCR Europe Limited is 3B BlackBio Dx Limited, which is majority shareholder incorporated and registered in India. Copies of the consolidated financial statements of 3B BlackBio Dx Ltd can be obtained from registered address 7-C, Industrial Area, Govindpura, Bhopal 462023 [M.P.], India.